-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
C4 Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q2 2024.
- C4 Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $6.38M, a 0.69% decline year-over-year.
- C4 Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $27.2M, a 6.05% increase year-over-year.
- C4 Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $27.2M, a 9.27% decline from 2022.
- C4 Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $30M, a 39.5% increase from 2021.
- C4 Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $21.5M, a 527% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)